Baker Avenue Asset Management’s Idexx Laboratories IDXX Stock Holding History

Baker Avenue Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$662K	Buy	1,257 +432	+52%	+$242K	0.01%	415
2026 Q1	$464K	Buy	825 +120	+17%	+$77K	0.01%	456
2025 Q4	$477K	Sell	705 -3	-0.4%	-$2.04K	0.01%	393
2025 Q3	$452K	Buy	+708	New	+$430K	0.01%	373
2023 Q4	–	Sell	-247	Closed	-$108K	–	883
2023 Q3	$108K	Sell	247 -26	-10%	-$13K	0.01%	413
2023 Q2	$137K	Sell	273 -1,112	-80%	-$533K	0.01%	379
2023 Q1	$693K	Buy	1,385 +1,168	+538%	+$559K	0.04%	217
2022 Q4	$88.5K	Sell	217 -474	-69%	-$184K	0.01%	422
2022 Q3	$225K	Sell	691 -304	-31%	-$112K	0.01%	320
2022 Q2	$349K	Buy	995 +187	+23%	+$76.3K	0.02%	254
2022 Q1	$442K	Sell	808 -837	-51%	-$440K	0.02%	228
2021 Q4	$1.08M	Buy	1,645 +1,129	+219%	+$709K	0.05%	160
2021 Q3	$320K	Buy	+516	New	+$347K	0.02%	214
2020 Q1	–	Sell	-5,662	Closed	-$1.48M	–	221
2019 Q4	$1.48M	Sell	5,662 -370	-6%	-$97.5K	0.11%	123
2019 Q3	$1.64M	Buy	6,032 +224	+4%	+$62.3K	0.13%	107
2019 Q2	$1.6M	Buy	5,808 +108	+2%	+$26.6K	0.13%	109
2019 Q1	$1.27M	Buy	+5,700	New	+$1.18M	0.1%	123

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Baker Avenue Asset Management's IDXX Position: Q2 2026 in Review

Baker Avenue Asset Management increased its Idexx Laboratories (IDXX) stake by 52% in Q2 2026, buying an estimated $242K and bringing the position to 1,257 shares worth $662K. The position accounts for 0.01% of the portfolio, ranked #415.

Baker Avenue Asset Management first reported a position in IDXX in Q1 2019 and has held it in 17 quarters since. The position peaked at $1.64M in Q3 2019. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Baker Avenue Asset Management held 1,257 shares of Idexx Laboratories worth $662K as of Q2 2026.
Baker Avenue Asset Management bought 432 Idexx Laboratories shares in Q2 2026, an estimated $242K.
Idexx Laboratories made up 0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #415 holding.
Baker Avenue Asset Management first reported a position in Idexx Laboratories in Q1 2019 and has held it in 17 quarters since.
Baker Avenue Asset Management's Idexx Laboratories position peaked at $1.64M in Q3 2019.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.